Atlas Trials

Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)

Clinical trial NCT03262636 · COMPLETED

Trial details

NCT number
NCT03262636
Sponsor
University of Pennsylvania
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Brain Tumor, PrimaryBrain Tumor, Recurrent
Start date
2015-06-01
Primary completion
2020-03-10
Enrollment
363

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.